supp.fit

Black Cohosh: study protocols

20 study groups say how much Black Cohosh participants took a day. These are the doses the studies gave. They are not a recommendation.

Black Cohosh: what the research found →

Dose per serving from products

465 products in our catalogue print how much Black Cohosh a serving holds.

Most common: 25 mg to 50 mg, 31% of 465 products.

Dose per servingProducts
10 mg or less
8
10 mg to 25 mg
25
25 mg to 50 mg
142
50 mg to 100 mg
82
100 mg to 250 mg
99
250 mg to 500 mg
26
500 mg to 1 g
80
over 1 g
3

Dose per serving from research

20 study groups in 18 studies say how much Black Cohosh participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 55% of 20 study groups.

Daily doseStudy groups
25 mg or less
1
25 mg to 50 mg
11
50 mg to 100 mg
3
100 mg to 250 mg
3
250 mg to 500 mg
0
500 mg to 1 g
1
over 1 g
1

Commonly used together

2 of 20 study groups took Black Cohosh with something else, but nothing that 3 or more different studies gave.

20 study groups

Study
Adding phytoestrogens to clomiphene induction in unexplained infertility patients--a randomized trial
2008 · group I · Women with unexplained infertility and recurrent clomiphene citrate induction failure
120 mg12 days60
First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055
2006 · CR BNO 1055 treatment · postmenopausal women with symptoms related to estrogen deficiency
40 mg52 weeks400
Role of phyto-oestrogens in ovulation induction in women with polycystic ovarian syndrome
2013 · C. racimosa group · Women with polycystic ovarian syndrome
20 mg—50
Effectiveness of the short-term use of Cimicifuga racemosa in the endothelial function of postmenopausal women: a double-blind, randomized, controlled trial
2020 · C. racemosa group · Healthy postmenopausal women; age range not reported
160 mg4 weeks31
Efficacy and safety evaluation of Cimicifuga foetida extract in menopausal women
2018 · group C · early postmenopausal women
100 mg2 years—
Effects of a combination of botanical actives on skin health and antioxidant status in post-menopausal women: A randomized, double-blind, placebo-controlled clinical trial
2022 · Treatment group · Postmenopausal women aged 45–60 with at least 12 months without consecutive monthly periods and facial type II–III fine lines and wrinkles
520 mg12 weeks55
Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone
2007 · iCR (isopropanolic Cimicifuga racemosa extract) · Women aged 40–60 years with menopausal symptoms and Kupperman Menopause Index (KMI) ≥15
40 mg90 days122
[Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms]
2009 · remifemin group · Postmenopausal women aged 40–60 with perimenopausal symptoms
40 mg12 weeks90
Efficacy and safety of remifemin on peri-menopausal symptoms induced by post-operative GnRH-a therapy for endometriosis: a randomized study versus tibolone
2014 · Remifemin group · Women with endometriosis after surgery who received GnRH-a therapy; age range not stated
40 mg12 weeks56
The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers
2003 · CR BNO 1055 · postmenopausal women
40 mg90 days—
Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms
2005 · isopropanolic black cohosh extract · Women with climacteric complaints; age range not reported
40 mg12 weeks—
Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol
2005 · Cimicifuga racemosa (CR) extract · Postmenopausal women with climacteric complaints; age and sex beyond this description were not stated
40 mg90 days—
Comparison Of Cimicifuga foetida extract and different hormone therapies regarding in causing breast pain in early postmenopausal women
2019 · group C · Early postmenopausal women
99.9 mg26 weeks—
Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine
2002 · phytoestrogen preparation · Women with menstrually associated migraine
50 mg24 weeks—
Pharmacokinetics of 23-epi-26-deoxyactein in women after oral administration of a standardized extract of black cohosh
2010 · four-capsule group · Healthy menopausal women aged 45–59 years
128 mg1 day5
Pharmacokinetics of 23-epi-26-deoxyactein in women after oral administration of a standardized extract of black cohosh
2010 · one-capsule group · Healthy menopausal women aged 45–59 years
32 mg1 day5
Pharmacokinetics of 23-epi-26-deoxyactein in women after oral administration of a standardized extract of black cohosh
2010 · two-capsule group · Healthy menopausal women aged 45–59 years
64 mg1 day5
Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans
2006 · Black cohosh · Healthy young adults; 8 women and 8 men, mean age 26 years
40 mg2 weeks16
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes
2005 · black cohosh supplementation · 12 healthy young adults, mean age 24 ± 3 years; 6 female
2.18 g4 weeks12
Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study
2006 · CR (Cimicifuga racemosa) · Postmenopausal women; age range and other conditions not reported
40 mg12 weeks—